Several other studies have shown that blood levels of IL-8 and IL-6 are increased and are associated with poor prognosis in RCC patients, as well as their role in promoting angiogenesis and suppressing the cytotoxic effect of immune cells [18,19]. The gene discussed is CXCL8; the disease is renal cell carcinoma.